CLINICAL_TRIALS
trial_result
· 2026-01-21
Clinical Trial Update: High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m) [NA]
Summary
A completed clinical trial from the University of Zurich evaluated pulmonary artery pressure in high-altitude residents with high altitude pulmonary hypertensio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED